Taking aim at novel vaccines market.
The World Vaccine Congress Washington 2009 was held in Chantilly, VA USA April 2O -23rd. The Vaccine congress attracted over 400 participants from across the world, including leading vaccine manufacturers, biotechs, governmental agencies, NGOs, research and academic institutes, venture capital and legal firms, contract service and equipment manufacturers. The speakers covered a wide range of topics, including the role of government and regulatory agencies, funding availability, research and development, manufacturing, packaging and post vaccine evaluations. Past vaccine development efforts have historically focused on infectious diseases. With advancements in the field of immunology, molecular biology and vaccinology, the vaccine field has begun moving in new directions. "Taking aim at novel vaccines market" session chaired by Dr. Una Ryan, Chief Executive Officer of Waltham Technologies, was focused on traditional approaches to novel targets (nosocomial infections), novel approaches to traditional targets (flu and rabies), novel approaches to novel targets (Type 1 diabetes, multiple sclerosis and smoking) and vaccines for developing markets (TB, malaria, rabies). The importance of collaborations among academic institutions, industries, and philanthropic foundations for developing markets was also emphasized.
Awasthi
Sita
S
Infectious Disease Division, Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. sawasthi@mail.med.upenn.edu
D035843:Biomedical Research / Q000191:economics / Q000639:trends; D003141:Communicable Diseases / Q000276:immunology*; D004219:District of Columbia; D017277:Drug Approval; D004345:Drug Industry / Q000639:trends; D006291:Health Policy; D006801:Humans; D012106:Research / Q000191:economics / Q000639:trends; D014611:Vaccination / Q000706:statistics & numerical data*; D014612:Vaccines / Q000276:immunology*
D014612:Vaccines